Skip to main content

Want a detailed portfolio tracker?

Performance analysis of VYNE Therapeutics (VYNE)

Annual Return

Over the past 3 years, VYNE has had an average annual return of -53.09%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, VYNE has had an average annual return of -61.10%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Jan 25, 2018, VYNE has had an average annual return of -62.11%, underperforming the benchmark SPY, which returned +14.17% annual.

202620252024202320222021202020192018
+0%-81.25%+45.45%-15.38%-85.39%-83.82%-65.97%+12.61%-85.65%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+0%+0%+0%+0%+0%+0%+0%
2025-31.25%+9.09%-33.33%-25.00%-16.67%+60%-75.00%+0%+0%+0%+0%+50%-81.25%
2024-27.27%+37.50%+36.36%-20.00%-0%-16.67%-10.00%+0%+0%+44.44%+7.69%+14.29%+45.45%
2023+76.92%-30.43%-6.25%+66.67%+20%-33.33%+10%-4.55%-4.76%-25.00%+6.67%-31.25%-15.38%
2022-39.33%-12.96%+21.28%-35.09%-5.41%-2.86%+11.76%-28.95%-29.63%+15.79%-9.09%-35.00%-85.39%
2021+25.45%-5.80%-8.31%-27.85%-20.00%-11.05%-23.20%-37.02%-18.24%-3.31%-23.08%-1.11%-83.82%
2020-0.87%-35.83%-9.24%-32.05%+31.23%-27.52%-6.97%-4.99%+8.44%-3.63%+6.28%-7.09%-65.97%
2019+29.83%+59.10%-7.76%-8.27%-6.54%-11.01%-36.72%+29.85%-8.98%+13.21%-21.91%+17.19%+12.61%
2018+28.18%-6.39%+9.09%-78.69%+4.48%-2.98%+0.50%-5.88%+28.26%-38.06%-1.51%-31.44%-85.65%

Drawdown analysis of VYNE Therapeutics (VYNE)

The maximum drawdown for the VYNE was -99.99%, occurring on Sep 5, 2025. This drawdown has not yet recovered.

The current VYNE drawdown is -99.98%.

Since Jan 25, 2018 VYNE has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Mar 28, 20181870Sep 5, 2025OngoingOngoingOngoing
-19.02%Jan 31, 201833Mar 20, 20186Mar 28, 201839
-0.70%Jan 25, 20181Jan 26, 20181Jan 29, 20182